Josh Levitsky
MD, MS
Northwestern University
Appearances
Topic #4 (Liver)
Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights
Overview of immunosuppression in liver transplant recipients
Living Donor Issues: Liver
Deceased Donor Management and Organ Preservation
Panel Discussion: Overview of Current Allocation by Organ - How Can We Increase Deceased Donor Utilization?
Renal Dysfunction in Non-Kidney Organ Transplants: Liver, Heart, Lung
Management of DSA Across all Organ Transplants
With All Our Drugs, Why Can’t We Develop Evidence-based, Individualized Immunosuppression
Controversies in Liver-Kidney (2019)
Deceased Donor Management and Organ Preservation: Who does it best? Kidney Preservation, Liver Perfusion, Ex Vivo Lung
Overview of Current Allocation by Organ - How Can We Increase Deceased Donor Utilization?
Key Clinical Trials in Heart, Lung, and Liver
Transplant Trivia!
Case Studies: Navigating Equity and Utility in the Real World - Option 1 (Liver and Kidney)
Session 6: Option 1: Liver Track - Immunosuppression Monitoring and Endpoints